SCHEDULE 13G/A: KCK Ltd. and Nael Karim Kassar Maintain 8.6% Stake in Sight Sciences, Inc.
Beneficial Ownership Disclosure
KCK Ltd. and Nael Karim Kassar have reported a shared beneficial ownership of 8.6% in Sight Sciences, Inc., totaling 4,374,975 common shares as of December 31, 2024.
Summary
- KCK Ltd. and Nael Karim Kassar jointly hold 4,374,975 shares of Sight Sciences, Inc. Common Stock.
- This ownership represents 8.6% of the company's outstanding Common Stock.
- The ownership percentage is calculated based on 50,754,616 outstanding shares of Common Stock, as reported in Sight Sciences, Inc.'s Form 10-Q filed on November 7, 2024.
- Both KCK Ltd. (a Bermuda entity) and Nael Karim Kassar (a French citizen) possess shared voting power and shared dispositive power over these 4,374,975 shares.
- This filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously disclosed beneficial ownership position.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing beneficial ownership, providing factual information without inherent positive or negative sentiment regarding company performance.
Positives
- The disclosure of a significant 8.6% stake by KCK Ltd. and Nael Karim Kassar indicates a notable investment by a sophisticated party, which can be viewed as a vote of confidence in Sight Sciences, Inc.
Future Outlook
The document is a regulatory filing disclosing beneficial ownership and does not contain forward-looking statements or guidance.
Management Comments
- "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."
Industry Context
This filing is a standard regulatory disclosure of a significant ownership stake in a publicly traded company. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2024-11-07 | Date of Issuer's Form 10-Q filing, which reported 50,754,616 outstanding shares of Common Stock. |
| 2024-12-31 | Date of event which requires the filing of this statement (reporting period end date). |
| 2025-02-11 | Signature date of the Schedule 13G Amendment No. 2. |
Keywords
Sight Sciences Inc., KCK Ltd., Nael Karim Kassar, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Shareholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.